Assessing Lameness Severity in Horses with Chronic Laminitis
Alexandra Beckstett
November 20, 2011
The use of force plate-based technology could quantify lameness severity in chronically laminitic horses.
Laminitis (commonly called “founder”) affects an estimated 7-14% of the world’s equine population. It’s the inflammation of the tiny, interwoven lamellae that attach a horse’s hoof to the underlying coffin bone (third phalanx, or P3) and support the horse’s entire body weight. Anything that impacts the integrity of the lamellae, such as inflammation, weakens their hold. This causes the coffin bone to displace within the hoof capsule and move toward the ground. The condition is very painful and is often life-threatening to horses.
The same disease has several different causes, which include:
The use of force plate-based technology could quantify lameness severity in chronically laminitic horses.
An upcoming laminitis project sponsored by the AAEP Foundation and conducted by Texas A&M University researchers will collect case information from veterinarians across the country. It will be one of the largest studies of the disease ever conducted.
The International Equine Conference on Laminitis and Diseases of the Foot features an expanded poster session.
Increasing the palmar angle could increase the amount of pressure on dorsal laminae rather than decreasing it.
Researchers recently set out to examine how pregnancy impacts insulin sensitivity and glucose levels.
The 1999 Breeders’ Cup Distaff winner was euthanized after a battle with equine laminitis.
Supporting limb laminitis is a sometimes fatal condition that develops as the result of another injury.
Is inflammation involved in chronic laminitis development in horses with equine metabolic syndrome?
As lush summer grass grows, unfortunately so does your horse’s risk for laminitis.
The Sanctuary Equine Sports Therapy & Rehabilitation Center will offer a “Lameness and Laminitis Symposium” on
Full brother to 2006 Kentucky Derby winner born five years after Barbaro sustained injury in the Preakness.
“The Horse Owner’s Guide to Regenerative Medicine” will take place June 4 from 2:00 to 5:00 p.m., in Lexington
The Equine Cushing’s and Insulin Resistance Group (ECIR Group) recently announced plans for the First Annual No Laminitis! Conference to take place on Aug. 5-7, 2011, hosted by Black Horse Consulting in conjunction with DeMario Farms of Chittenango,
Learn about equine metabolic syndrome and its relationship to laminitis, recognizing and managing at-risk horses to prevent laminitis, and more with Dr. Raymond Geor of Michigan State University.
Recent surveys of equine veterinarians reveal that laminitis is the No. 1 lameness concern of equine practitioners, due how difficult it is to treat and manage this debilitating condition. On the topic of laminitis control, Heidi Reesink, VMD, a
The National Thoroughbred Racing Association’s (NTRA) subsidiary, NTRA Charities, has announced that the Barbaro Fund for Equine Health and Safety Research has disbursed $49,000 to support the second year of a research project on laminitis. The funds
Stay on top of the most recent Horse Health news with
